Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Conference Agenda

Day 1

Opening Keynotes
The next step forward & Culture change
08:30 - 09:00
Your role in healthcare delivery: understand society’s expectations alongside meeting commercial imperatives
  • Understand how changes to HCP evaluation, payer reimbursement, regulator requirements and patient perspectives will transform the demands of our industry
  • Where must your company step up to play a greater role in preventative health and disease management?
  • Appreciate how we need to address social, financial and community issues in order for our medicines to have maximum impact

Sanofi Anne Beal Chief Patient Officer Sanofi

08:30 - 09:00
Patient Centricity: from Buzzword to Reality
  • Learn how the best companies are transitioning from talking about patient centricity into co-creating meaningful patient centric solutions
  • Determine the strategy and patient centric approaches that can bring increased value to patients across the product lifecycle
  • Understand where the pillars of patient centricity can be implemented to better support R&D and Commercial organizations

zs_associates Aaron Mitchell Managing Principal ZS

zs_associates Hensley Evans Principal ZS

08:30 - 09:00
PANEL: The real opportunity behind 'unmet needs'
  • Challenge what we really mean when discussing ‘unmet needs’ and how they should be captured and understood
  • Reverse your mentality – discover patient needs before creating a product or solution – and evaluate what targets to aim for
  • Assess the best methodology for understanding unmet needs both qualitatively AND quantitatively in order to prioritize your activities

Moderator: - Heidi Floyd Author, Patient, Advocate, Speaker

Allergan Gavin Corcoran Chief Medical Officer Allergan

Medicines360 Jessica Grossman Chief Executive Officer Medicines360

Sanofi Divya Mishra Aidoud Associate Director, New Product Planning Market Research Sanofi

GlaxoSmithKline Marilyn Metcalf Head, Center of Innovation & Patient Engagement Lead GlaxoSmithKline

08:30 - 09:00
Session from Health Advocacy Strategies

More information to follow

health_advocacy_strategy__patient_health_perspectives


Speaker to be revealed - check back for updates

08:30 - 09:00
PANEL: Where culture eats strategy: start by enabling a patient-first model to flourish organically
  • Make the shift by moving your firm to assess value from BOTH the eyes of the physician AND the patient
  • Avoid mandatory training by supporting your colleagues to invest and take pro-active steps to engage with patients in all cross-functional areas
  • Learn from successful transformations to determine whether culture change should be top-down or bottom-up
  • Drive real change by critically assessing patients’ experience and linking progress to your strategic goals

Astellas Doug Noland Patient Experience Executive Director Astellas

Sanofi Genzyme Gabriela Mondino Head of US Public Affairs and Advocacy Sanofi Genzyme

Janssen Christine MacCracken Director, Patient Support Janssen

Luck Fupus MarlaJan Wexler Patient, Lupus Advocate and Blogger Luck Fupus

Want to hear from these expert speakers? Register now!

Save $100 if you register before October 6th

Patient Pathways & Services
Improving patient experience & Accessibility
Patient-led Clinical
Rethink clinical trials & Approvals
10:30 - 11:00
The importance of patient advocacy and its role in cultivating a patient-centric environment
  • Discuss best practice in integrating patient perspective in all relevant areas of business and product lifecycle through collaboration with patient advocacy organizations
  • Learn how to provide meaningful benefit to patients by prioritizing patient health and outcomes over products
  • Incorporate patient-centric strategies to help patients find solutions, tools and information that help them focus on costs, quality and access

Amgen Tom Croce Vice President, Global Advocacy Relations Amgen

A systematic approach for incorporating the patient voice into trial design
  • Establish where embedding patient insights into development and protocol setup makes practical sense
  • Create policies, tools, best practice case studies and enabling support to facilitate patient input in trial design across the company
  • Drive culture change and metrics evaluation of patient input into trial design
  • Re-think the way R&D is evaluated – is the ‘first patient in’ timeline model incongruous with getting early patient insight?

Novartis Cathryn Clary Global Head, Patient Affairs and Policy, Chief Medical Office Novartis

10:30 - 11:00
Transforming the Moment of Care

More information to follow

Outcome Health Roger Sawhney Senior Vice President of Life Sciences Strategy and Business Development Outcome Health

Patient recruitment isn't about numbers: make meaningful and lasting connections with patients to set your studies up for success
  • Learn what location, stakeholders and personas have in common; and how they each can impact your study
  • Yield quality patients, enhance site performance and achieve greater study success by engaging with the right stakeholders at the right time in your study

Bioclinica Martin Collyer Chief Operating Officer Patient Recruitment Bioclinica

10:30 - 11:00
Teva's global engagement campaign – the pitfalls and positives
  • Learn how Teva took an honest and frank look at the pharmaceutical industry and the way it does business, whilst listening to the concerns of those accessing healthcare
  • Insights into how to build trust and understand the real issues facing patients
  • Understand the opportunities that will follow from working collaboratively and developing sustainable solutions which address the needs of patients

Teva Ruth Wilson Global Head of Patient Advocacy Teva

Turn patient insights into science
  • Get patient insights early to become strategic rather than reactive
  • Hear how unexpected patient insights have helped moderate protocols and trial design endpoints before the trial begins
  • Examples which demonstrate how patient insights have led to improvements in trial enrolment speed, retention and access

ViiV Healthcare Frank Spinelli Medical Director, Patient Affairs, US ViiV Healthcare

10:30 - 11:00
PANEL: Make patient involvement routine – and more relevant
  • Facilitate patient and caregiver involvement with your organization
  • Approaches that allow for internal stakeholders to access relevant insights from patients and caregivers’ organizations
  • Make your system easier for patients to interact with – and for employees to initiate
  • Incorporate innovative engagement approaches that allow for virtual input and engagement

Boehringer Ingelheim Jaye Bea Smalley Associate Director, Patient Advocacy and Professional Relations-Patient Engagement Boehringer Ingelheim

Eli Lilly and Company Joseph Kim Senior Advisor, Clinical Innovation Eli Lilly and Company

Fight Colorectal Cancer Nancy Roach Founder Fight Colorectal Cancer

FDA Perspective: Clinical Trial Inclusion - Challenges and Opportunities
  • Outline the issue of lack of diversity in clinical trials and why it is crucial that it be addressed
  • Present FDA clinical trial inclusion data to illustrate the depth of the problem
  • Discuss how FDA is addressing clinical trial diversity through policy and outreach and communication

FDA Martin Mendoza Director of Extramural Research, Office of Minority Health FDA

10:30 - 11:00
Solutions that stick: Designing innovative patient support in a complex ecosystem
  • Mapping the baseline – understand the parameters that shape effective program design
  • Design tools and services that improve outcomes for patients
  • Strategies for de-risking programs in a regulated industry
  • Decision-making in a dynamic environment

Otsuka America Shabnam Kazmi Vice President, Patient Access & Adherence Otsuka America

Overcoming barriers to increased clinical trial diversity and inclusion
  • Understand the compelling data reality
  • Discuss overcoming barriers through a multi-stakeholder approach
  • Discuss opportunities for enrollment of diverse patient populations in clinical research

Merck Luther Clark Global Director, Scientific, Medical and Patient Perspective Merck

Merck Mary Elmer Associate Director, Global Patient Engagement Strategy Office Merck

10:30 - 11:00
Patient Centric Marketing Strategy and Patient Support
  • Understand how to deepen patient insights to uncover holistic patient needs and design an end-to-end patient experience
  • Determine how to engage with patients to co-create meaningful programs and services for patients and caregivers
  • Evaluate various approaches to impact measurement leveraging the four pillars

ZS Associates Hensley Evans Principal ZS

Patient Centric Drug Development
  • Understand how to advocate and implement patient centric programs in R&D
  • Gain insight into how the pillars of patient centricity can be implemented into clinical development, to include case studies from industry
  • Identify approaches to gain a deep understanding of patient needs and co-create meaningful solutions for patients and their caregivers in clinical development

ZS Associates Aaron Mitchell Managing Principal ZS

10:30 - 11:00
Bridging the lines of communication between biopharma and the patient advocacy community 
  • Recognize differences and identify agendas involved when engaging with a rare disease community
  • Establish mutual understanding and uncover methods of respectful communication
  • Grow the trust needed in order to meet outcomes

Living in the Light LLC Levi Gershkowitz Founder and Executive Director Living in the Light LLC

EDSers United Foundation Nadia Bodkin Pharm.D., M.S., Board Member EDSers United Foundation

Audentes Therapeutics Barbara Wuebbels Vice President of Global Patient Relations Audentes Therapeutics

Sangamo Therapeutics Heather Erickson Chief of Staff Sangamo Therapeutics

Applying patient preferences in a phase 3 Multiple Sclerosis trial
  • Hear how regulatory authority requirements are changing regarding the inclusion of patient preferences in the regulatory decision making process
  • Understand why the method for collecting this data should be grounded in the principles of decision theory to be easily integrated into a clinical trial or post-authorization setting
  • Learn about Actelion’s Measuring Attractiveness by a Categorical Based Evaluation TecHnique (MACBETH) approach and how it is being used to elicit preferences from MS patients in an ongoing phase 3 trial

Actelion Daniele D’Ambrosio Senior Director, Clinical Science Program Head Actelion

Want to hear from these expert speakers? Register now!

Save $100 if you register before October 6th

Day 2

Patient Pathways & Services
Legal and compliance & Patient-centric management
Patient-led Clinical
Digital & Data
10:30 - 11:00
Learn from other highly regulated industries – case studies which you can apply to your business
  • Understand how retail has captured and applied consumer insights using technology
  • Learn how financial organisations have worked in partnership with regulators to co-design smart solutions with customer interests at their heart
  • A look at how hospitals have managed to roll out trials more quickly and how you could obtain similar agility
  • See where the aviation industry has made long term partnerships with selected ‘launch customers’ to help them understand and navigate a highly regulated, capital-intense model

Speaker to be revealed - check back for updates

Leapfrog your competitors with smarter use of digital tools in clinical research
  • What’s possible? An exploration of digital strategies in existing and upcoming trials
  • What’s useful? A critical look at digital support with patient retention in trials
  • What’s coming? A look at potential new solutions which promise to accelerate development
  • What else? How digital tools support other value-added services alongside drug therapy

Patient and Partners LLC Cindy Geoghegan Principal Patient and Partners LLC

10:30 - 11:00
A case study on how to overcome the barriers to patient involvement
  • Set up a process for keeping abreast of regulations across each region you work in
  • Ways to involve your legal team in establishing how best to work with patients in development, so they can the nature of insights that will be obtained

Speaker to be revealed - check back for updates

Leverage EHRs to support population health management and drive patient engagement
  • Learn how to utilize EHRs to support managing chronic populations
  • Understand how to position EHRs to be a driving force in patient engagement
  • Focus on the patient journey to create synergies across the care continuum

Boehringer Ingelheim Patricia Cunningham Associate Director Health Information Technology Boehringer Ingelheim

10:30 - 11:00
The journey to the beginning: How AstraZeneca defined patient centricity and the impact on the organisation
  • Learn how AZ has established some basic principles for a patient centric transformation program as it begins to refocus on how to engage patients
  • Listen to how AZ is creating that momentum for change to build sustainable practices for the future
  • How is AZ demonstrating impact for patients?

AstraZeneca Dawn DiCandilo Patient Centricity Excellence Director AstraZeneca

PANEL: Create actionable insights by mapping the patient journey through data
  • Understand the patient experience in real life, beyond trials, by collecting meaningful data
  • Learn how data on patient experience can improve your programs long-term
  • Drive tangible benefits including increased adherence, reduced cost and patient and payer engagement

Janssen Ramana Sonty Director of Strategy, Global Medical Organization Janssen

ViiV Healthcare Frank Spinelli Medical Director, Patient Affairs, US ViiV Healthcare

American Living Organ Donor Fund Michael Mittelman VP Patient Advocacy & Strategic Partnerships American Living Organ Donor Fund

10:30 - 11:00
A roadmap to working with patients in an ethical and transparent manner
  • Establish firm principles and a generic engagement framework
  • Incorporate patient insights faster and overcome barriers
  • Understand how to navigate regional differences in regulations and mindsets

Speaker to be revealed - check back for updates

The next step for BMS’ Universal Patient Language – a guide to implementation
  • A look at how BMS’ patient experience has been transformed since the inception of the UPL for patient communications
  • Learn how the UPL is now being used to redesign informed consent forms for clinical trials and other areas of patient engagement
  • Better engage patients and improve their experience with an easier to navigate engagement process

Bristol-Myers Squibb Debra Reinhard Lead, Translational Medicine Enabling Solutions Bristol-Myers Squibb

Bridgeable Susan Bartlett Principle Bridgeable

10:30 - 11:00
Benefit from an enterprise-wide engagement process when developing strong patient capabilities
  • Avoid duplication and improve communication with centralized co-ordination of patient-centric efforts
  • Ensure organizational transparency and rapid access for all functional areas via a portal with tools and resources
  • Instil a process to help teams know how and when to engage with patients
  • Create a personalized patient experience regardless of their touchpoint with your organization

Speaker to be revealed - check back for updates

How greater data-sharing and collaboration advances drug development and benefits all stakeholder
  • Benefits of multi-sector collaboration
  • How data collaboration accelerates development across industries and sectors
  • How a data-sharing in a cross-sector consortium works to deliver meaningful results

Critical Path Institute Martha Brumfield President and CEO Critical Path Institute

Want to hear from these expert speakers? Register now!

Save $100 if you register before October 6th

Closing Keynotes
Patient experience & Measurement
08:30 - 09:00
Healthcare Trends 2018: The New Patient Experience (and Expectation)
  • See an exclusive preview of the eighth annual healthcare trends report from inVentiv Health Communications
  • Dig into important systemic shifts, like specialty pharmacies snapping up by PBMs, a sharp decline in people choosing to parent, a new focus on retail providers, prevention bringing an age-old conversation about compliance back to center stage, and accelerations in ultra-rare disease diagnosis
  • Understand important new mindsets in key segments of patients, including those disloyal to physicians, disengaged by new divides, and a significant new group finally leaning in
  • Learn about new patient experiences and behaviors, like more people finding medicine in the comforting glow of their screens, a new push to support “elder orphans,” data-driven nudges, and home delivery of just about everything health
  • Get first access to new data on patient perspectives on virtual nurse assistants and the next generation of AI-powered patient support

inventiv_health_communications_tag


Speaker to be revealed - check back for updates

08:30 - 09:00
PANEL: Enhancing the patient access and experience in a clinical trial through collaboration: TransCelerate's innovative approaches
  • Hear about plans to create greater understanding of clinical research and clinical trial opportunities for patients and their health care professionals
  • What efforts and innovative technologies can enhance the patient experience and reduce patient burden in clinical trials
  • How capabilities like eConsent and eLabels can be used to empower patients, families, and providers

MODERATOR: UCB Stephen Yates Clinical Program Director and Head, Patient Engagement Strategy UCB

Merck Madeline Geday Associate Director, Patient and Stakeholder Engagement Lead Merck

Bristol-Myers Squibb Debra Reinhard Lead, Translational Medicine Enabling Solutions Bristol-Myers Squibb

Eli Lilly and Company Joseph Kim Senior Advisor, Clinical Innovation Eli Lilly and Company

- James Metcalf Patient

08:30 - 09:00
Understand your goals to instil the right measurement and evaluation criteria
  • Appreciate which practises need to change before you can begin to measure progress
  • Make sure there is endorsement of what will be measured, and keep things simple in order to drive behaviour
  • See how the results will follow as you incorporate increasingly more patient insights across your organization

Janssen Katherine Capperella Global Patient Engagement Leader Janssen

Want to hear from these expert speakers? Register now!

Save $100 if you register before October 6th

Day 1

Opening Keynotes
The next step forward & Culture change
08:30 - 09:00
Your role in healthcare delivery: understand society’s expectations alongside meeting commercial imperatives
  • Understand how changes to HCP evaluation, payer reimbursement, regulator requirements and patient perspectives will transform the demands of our industry
  • Where must your company step up to play a greater role in preventative health and disease management?
  • Appreciate how we need to address social, financial and community issues in order for our medicines to have maximum impact

Sanofi Anne Beal Chief Patient Officer Sanofi

08:30 - 09:00
Patient Centricity: from Buzzword to Reality
  • Learn how the best companies are transitioning from talking about patient centricity into co-creating meaningful patient centric solutions
  • Determine the strategy and patient centric approaches that can bring increased value to patients across the product lifecycle
  • Understand where the pillars of patient centricity can be implemented to better support R&D and Commercial organizations

zs_associates Aaron Mitchell Managing Principal ZS

zs_associates Hensley Evans Principal ZS

08:30 - 09:00
PANEL: The real opportunity behind 'unmet needs'
  • Challenge what we really mean when discussing ‘unmet needs’ and how they should be captured and understood
  • Reverse your mentality – discover patient needs before creating a product or solution – and evaluate what targets to aim for
  • Assess the best methodology for understanding unmet needs both qualitatively AND quantitatively in order to prioritize your activities

Moderator: - Heidi Floyd Author, Patient, Advocate, Speaker

Allergan Gavin Corcoran Chief Medical Officer Allergan

Medicines360 Jessica Grossman Chief Executive Officer Medicines360

Sanofi Divya Mishra Aidoud Associate Director, New Product Planning Market Research Sanofi

GlaxoSmithKline Marilyn Metcalf Head, Center of Innovation & Patient Engagement Lead GlaxoSmithKline

08:30 - 09:00
Session from Health Advocacy Strategies

More information to follow

health_advocacy_strategy__patient_health_perspectives


Speaker to be revealed - check back for updates

08:30 - 09:00
PANEL: Where culture eats strategy: start by enabling a patient-first model to flourish organically
  • Make the shift by moving your firm to assess value from BOTH the eyes of the physician AND the patient
  • Avoid mandatory training by supporting your colleagues to invest and take pro-active steps to engage with patients in all cross-functional areas
  • Learn from successful transformations to determine whether culture change should be top-down or bottom-up
  • Drive real change by critically assessing patients’ experience and linking progress to your strategic goals

Astellas Doug Noland Patient Experience Executive Director Astellas

Sanofi Genzyme Gabriela Mondino Head of US Public Affairs and Advocacy Sanofi Genzyme

Janssen Christine MacCracken Director, Patient Support Janssen

Luck Fupus MarlaJan Wexler Patient, Lupus Advocate and Blogger Luck Fupus

Want to hear from these expert speakers? Register now!

Save $100 if you register before October 6th

Patient Pathways & Services
Improving patient experience & Accessibility
Patient-led Clinical
Rethink clinical trials & Approvals
10:30 - 11:00
The importance of patient advocacy and its role in cultivating a patient-centric environment
  • Discuss best practice in integrating patient perspective in all relevant areas of business and product lifecycle through collaboration with patient advocacy organizations
  • Learn how to provide meaningful benefit to patients by prioritizing patient health and outcomes over products
  • Incorporate patient-centric strategies to help patients find solutions, tools and information that help them focus on costs, quality and access

Amgen Tom Croce Vice President, Global Advocacy Relations Amgen

A systematic approach for incorporating the patient voice into trial design
  • Establish where embedding patient insights into development and protocol setup makes practical sense
  • Create policies, tools, best practice case studies and enabling support to facilitate patient input in trial design across the company
  • Drive culture change and metrics evaluation of patient input into trial design
  • Re-think the way R&D is evaluated – is the ‘first patient in’ timeline model incongruous with getting early patient insight?

Novartis Cathryn Clary Global Head, Patient Affairs and Policy, Chief Medical Office Novartis

10:30 - 11:00
Transforming the Moment of Care

More information to follow

Outcome Health Roger Sawhney Senior Vice President of Life Sciences Strategy and Business Development Outcome Health

Patient recruitment isn't about numbers: make meaningful and lasting connections with patients to set your studies up for success
  • Learn what location, stakeholders and personas have in common; and how they each can impact your study
  • Yield quality patients, enhance site performance and achieve greater study success by engaging with the right stakeholders at the right time in your study

Bioclinica Martin Collyer Chief Operating Officer Patient Recruitment Bioclinica

10:30 - 11:00
Teva's global engagement campaign – the pitfalls and positives
  • Learn how Teva took an honest and frank look at the pharmaceutical industry and the way it does business, whilst listening to the concerns of those accessing healthcare
  • Insights into how to build trust and understand the real issues facing patients
  • Understand the opportunities that will follow from working collaboratively and developing sustainable solutions which address the needs of patients

Teva Ruth Wilson Global Head of Patient Advocacy Teva

Turn patient insights into science
  • Get patient insights early to become strategic rather than reactive
  • Hear how unexpected patient insights have helped moderate protocols and trial design endpoints before the trial begins
  • Examples which demonstrate how patient insights have led to improvements in trial enrolment speed, retention and access

ViiV Healthcare Frank Spinelli Medical Director, Patient Affairs, US ViiV Healthcare

10:30 - 11:00
PANEL: Make patient involvement routine – and more relevant
  • Facilitate patient and caregiver involvement with your organization
  • Approaches that allow for internal stakeholders to access relevant insights from patients and caregivers’ organizations
  • Make your system easier for patients to interact with – and for employees to initiate
  • Incorporate innovative engagement approaches that allow for virtual input and engagement

Boehringer Ingelheim Jaye Bea Smalley Associate Director, Patient Advocacy and Professional Relations-Patient Engagement Boehringer Ingelheim

Eli Lilly and Company Joseph Kim Senior Advisor, Clinical Innovation Eli Lilly and Company

Fight Colorectal Cancer Nancy Roach Founder Fight Colorectal Cancer

FDA Perspective: Clinical Trial Inclusion - Challenges and Opportunities
  • Outline the issue of lack of diversity in clinical trials and why it is crucial that it be addressed
  • Present FDA clinical trial inclusion data to illustrate the depth of the problem
  • Discuss how FDA is addressing clinical trial diversity through policy and outreach and communication

FDA Martin Mendoza Director of Extramural Research, Office of Minority Health FDA

10:30 - 11:00
Solutions that stick: Designing innovative patient support in a complex ecosystem
  • Mapping the baseline – understand the parameters that shape effective program design
  • Design tools and services that improve outcomes for patients
  • Strategies for de-risking programs in a regulated industry
  • Decision-making in a dynamic environment

Otsuka America Shabnam Kazmi Vice President, Patient Access & Adherence Otsuka America

Overcoming barriers to increased clinical trial diversity and inclusion
  • Understand the compelling data reality
  • Discuss overcoming barriers through a multi-stakeholder approach
  • Discuss opportunities for enrollment of diverse patient populations in clinical research

Merck Luther Clark Global Director, Scientific, Medical and Patient Perspective Merck

Merck Mary Elmer Associate Director, Global Patient Engagement Strategy Office Merck

10:30 - 11:00
Patient Centric Marketing Strategy and Patient Support
  • Understand how to deepen patient insights to uncover holistic patient needs and design an end-to-end patient experience
  • Determine how to engage with patients to co-create meaningful programs and services for patients and caregivers
  • Evaluate various approaches to impact measurement leveraging the four pillars

ZS Associates Hensley Evans Principal ZS

Patient Centric Drug Development
  • Understand how to advocate and implement patient centric programs in R&D
  • Gain insight into how the pillars of patient centricity can be implemented into clinical development, to include case studies from industry
  • Identify approaches to gain a deep understanding of patient needs and co-create meaningful solutions for patients and their caregivers in clinical development

ZS Associates Aaron Mitchell Managing Principal ZS

10:30 - 11:00
Bridging the lines of communication between biopharma and the patient advocacy community 
  • Recognize differences and identify agendas involved when engaging with a rare disease community
  • Establish mutual understanding and uncover methods of respectful communication
  • Grow the trust needed in order to meet outcomes

Living in the Light LLC Levi Gershkowitz Founder and Executive Director Living in the Light LLC

EDSers United Foundation Nadia Bodkin Pharm.D., M.S., Board Member EDSers United Foundation

Audentes Therapeutics Barbara Wuebbels Vice President of Global Patient Relations Audentes Therapeutics

Sangamo Therapeutics Heather Erickson Chief of Staff Sangamo Therapeutics

Applying patient preferences in a phase 3 Multiple Sclerosis trial
  • Hear how regulatory authority requirements are changing regarding the inclusion of patient preferences in the regulatory decision making process
  • Understand why the method for collecting this data should be grounded in the principles of decision theory to be easily integrated into a clinical trial or post-authorization setting
  • Learn about Actelion’s Measuring Attractiveness by a Categorical Based Evaluation TecHnique (MACBETH) approach and how it is being used to elicit preferences from MS patients in an ongoing phase 3 trial

Actelion Daniele D’Ambrosio Senior Director, Clinical Science Program Head Actelion

Want to hear from these expert speakers? Register now!

Save $100 if you register before October 6th

Day 2

Patient Pathways & Services
Legal and compliance & Patient-centric management
Patient-led Clinical
Digital & Data
10:30 - 11:00
Learn from other highly regulated industries – case studies which you can apply to your business
  • Understand how retail has captured and applied consumer insights using technology
  • Learn how financial organisations have worked in partnership with regulators to co-design smart solutions with customer interests at their heart
  • A look at how hospitals have managed to roll out trials more quickly and how you could obtain similar agility
  • See where the aviation industry has made long term partnerships with selected ‘launch customers’ to help them understand and navigate a highly regulated, capital-intense model

Speaker to be revealed - check back for updates

Leapfrog your competitors with smarter use of digital tools in clinical research
  • What’s possible? An exploration of digital strategies in existing and upcoming trials
  • What’s useful? A critical look at digital support with patient retention in trials
  • What’s coming? A look at potential new solutions which promise to accelerate development
  • What else? How digital tools support other value-added services alongside drug therapy

Patient and Partners LLC Cindy Geoghegan Principal Patient and Partners LLC

10:30 - 11:00
A case study on how to overcome the barriers to patient involvement
  • Set up a process for keeping abreast of regulations across each region you work in
  • Ways to involve your legal team in establishing how best to work with patients in development, so they can the nature of insights that will be obtained

Speaker to be revealed - check back for updates

Leverage EHRs to support population health management and drive patient engagement
  • Learn how to utilize EHRs to support managing chronic populations
  • Understand how to position EHRs to be a driving force in patient engagement
  • Focus on the patient journey to create synergies across the care continuum

Boehringer Ingelheim Patricia Cunningham Associate Director Health Information Technology Boehringer Ingelheim

10:30 - 11:00
The journey to the beginning: How AstraZeneca defined patient centricity and the impact on the organisation
  • Learn how AZ has established some basic principles for a patient centric transformation program as it begins to refocus on how to engage patients
  • Listen to how AZ is creating that momentum for change to build sustainable practices for the future
  • How is AZ demonstrating impact for patients?

AstraZeneca Dawn DiCandilo Patient Centricity Excellence Director AstraZeneca

PANEL: Create actionable insights by mapping the patient journey through data
  • Understand the patient experience in real life, beyond trials, by collecting meaningful data
  • Learn how data on patient experience can improve your programs long-term
  • Drive tangible benefits including increased adherence, reduced cost and patient and payer engagement

Janssen Ramana Sonty Director of Strategy, Global Medical Organization Janssen

ViiV Healthcare Frank Spinelli Medical Director, Patient Affairs, US ViiV Healthcare

American Living Organ Donor Fund Michael Mittelman VP Patient Advocacy & Strategic Partnerships American Living Organ Donor Fund

10:30 - 11:00
A roadmap to working with patients in an ethical and transparent manner
  • Establish firm principles and a generic engagement framework
  • Incorporate patient insights faster and overcome barriers
  • Understand how to navigate regional differences in regulations and mindsets

Speaker to be revealed - check back for updates

The next step for BMS’ Universal Patient Language – a guide to implementation
  • A look at how BMS’ patient experience has been transformed since the inception of the UPL for patient communications
  • Learn how the UPL is now being used to redesign informed consent forms for clinical trials and other areas of patient engagement
  • Better engage patients and improve their experience with an easier to navigate engagement process

Bristol-Myers Squibb Debra Reinhard Lead, Translational Medicine Enabling Solutions Bristol-Myers Squibb

Bridgeable Susan Bartlett Principle Bridgeable

10:30 - 11:00
Benefit from an enterprise-wide engagement process when developing strong patient capabilities
  • Avoid duplication and improve communication with centralized co-ordination of patient-centric efforts
  • Ensure organizational transparency and rapid access for all functional areas via a portal with tools and resources
  • Instil a process to help teams know how and when to engage with patients
  • Create a personalized patient experience regardless of their touchpoint with your organization

Speaker to be revealed - check back for updates

How greater data-sharing and collaboration advances drug development and benefits all stakeholder
  • Benefits of multi-sector collaboration
  • How data collaboration accelerates development across industries and sectors
  • How a data-sharing in a cross-sector consortium works to deliver meaningful results

Critical Path Institute Martha Brumfield President and CEO Critical Path Institute

Want to hear from these expert speakers? Register now!

Save $100 if you register before October 6th

Closing Keynotes
Patient experience & Measurement
08:30 - 09:00
Healthcare Trends 2018: The New Patient Experience (and Expectation)
  • See an exclusive preview of the eighth annual healthcare trends report from inVentiv Health Communications
  • Dig into important systemic shifts, like specialty pharmacies snapping up by PBMs, a sharp decline in people choosing to parent, a new focus on retail providers, prevention bringing an age-old conversation about compliance back to center stage, and accelerations in ultra-rare disease diagnosis
  • Understand important new mindsets in key segments of patients, including those disloyal to physicians, disengaged by new divides, and a significant new group finally leaning in
  • Learn about new patient experiences and behaviors, like more people finding medicine in the comforting glow of their screens, a new push to support “elder orphans,” data-driven nudges, and home delivery of just about everything health
  • Get first access to new data on patient perspectives on virtual nurse assistants and the next generation of AI-powered patient support

inventiv_health_communications_tag


Speaker to be revealed - check back for updates

08:30 - 09:00
PANEL: Enhancing the patient access and experience in a clinical trial through collaboration: TransCelerate's innovative approaches
  • Hear about plans to create greater understanding of clinical research and clinical trial opportunities for patients and their health care professionals
  • What efforts and innovative technologies can enhance the patient experience and reduce patient burden in clinical trials
  • How capabilities like eConsent and eLabels can be used to empower patients, families, and providers

MODERATOR: UCB Stephen Yates Clinical Program Director and Head, Patient Engagement Strategy UCB

Merck Madeline Geday Associate Director, Patient and Stakeholder Engagement Lead Merck

Bristol-Myers Squibb Debra Reinhard Lead, Translational Medicine Enabling Solutions Bristol-Myers Squibb

Eli Lilly and Company Joseph Kim Senior Advisor, Clinical Innovation Eli Lilly and Company

- James Metcalf Patient

08:30 - 09:00
Understand your goals to instil the right measurement and evaluation criteria
  • Appreciate which practises need to change before you can begin to measure progress
  • Make sure there is endorsement of what will be measured, and keep things simple in order to drive behaviour
  • See how the results will follow as you incorporate increasingly more patient insights across your organization

Janssen Katherine Capperella Global Patient Engagement Leader Janssen

Download the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown